Vitae Biomedical Co., Ltd. has achieved ISO 17025 certification for its protein analysis laboratory, demonstrating compliance with internationally recognized standards for laboratory quality and testing competence.

ISO 17025 is a globally accepted framework that ensures the reliability and validity of laboratory results through rigorous requirements across personnel training, equipment calibration, testing methodologies, and operational processes. The certification was granted by the Taiwan Accreditation Foundation (TAF), confirming that the company’s laboratory operations meet international benchmarks for accuracy and consistency.

This milestone reflects Vitae Biomedical’s continued investment in both research and quality management. By strengthening laboratory systems alongside technological development, the company ensures that its diagnostic results are not only innovative but also dependable and reproducible in real-world clinical settings.

Achieving ISO 17025 certification reinforces the credibility of Vitae Biomedical’s testing services and supports its ability to collaborate with international partners. It also enhances the company’s readiness for global market expansion, where standardized quality systems are essential for regulatory alignment and clinical trust.

Through the integration of robust quality management with advanced detection technologies, Vitae Biomedical continues to build a reliable foundation for non-invasive diagnostic solutions in precision healthcare.